. 2017 Jun 19;14(2):2393–2398. doi: 10.3892/ol.2017.6410

Table II.

Univariate analysis and multivariate analysis identifies factors affecting overall survival of patients with breast cancer.

	Univariate analysis			Multivariate analysis

Variables	RR	95% CI	P-value	RR	95% CI	P-value
TNFR2	3.428	1.03–11.404	0.045^a	3.36	0.624–18.107	0.158
Age	1.012	0.273–3.755	0.986	1.962	0.373–10.303	0.426
Menopausal status	0.374	0.119–1.172	0.091	1.073	0.126–9.125	0.948
Family history	0.672	0.182–2.483	0.551	2.315	0.398–13.472	0.35
Tumor size	16.156	4.821–54.138	<0.0001^a	0.256	0.047–1.407	0.117
Lymph involvement	2.493	0.674–9.215	0.171	0.425	0.065–2.79	0.373
Clinical stage	11.743	3.147–43.823	<0.0001^a	0.071	0.007–0.703	0.024^a
Pathological grade	6.48	2.04–20.584	0.002^a	0.371	0.057–2.395	0.297
Histological type	1.347	0.427–4.245	0.611	0.132	0.014–1.271	0.08
ER, PR and HER2	7.448	2.236–24.804	0.001^a	0.077	0.011–0.53	0.009^a

P<0.05. TNFR2, tumor necrosis factor receptor 2; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; RR, relative risk; CI, confidence interval.